HemCheck signs agreement with global SHL Group

HemCheck has signed a long-term agreement with SHL Technologies Limited, a subsidiary of the international SHL Group. The agreement entails SHL will manufacture the disposable tests that are used in HemCheck’s product concept, Helge, for point of care hemolysis detection. HemCheck’s goal is to CE-mark and launch Helge on the Swedish market during 2018.